Clinical Trials
11
Active:0
Completed:8
Trial Phases
3 Phases
Phase 2:1
Phase 3:5
Phase 4:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 3
5 (45.5%)Phase 4
5 (45.5%)Phase 2
1 (9.1%)A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants
- First Posted Date
- 2025-06-08
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Fidec Corporation
- Target Recruit Count
- 740
- Registration Number
- NCT07010822
- Locations
- 🇧🇩
icddr,b - Matlab Health Research Centre, Chandpur, Dhaka, Bangladesh
A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2
Phase 4
Completed
- Conditions
- Poliomyelitis
- First Posted Date
- 2023-01-10
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Fidec Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT05677256
- Locations
- 🇧🇩
International Centre for Diarrhoeal Diseases Research, Dhaka, Bangladesh
Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine
Phase 3
Withdrawn
- Conditions
- Poliomyelitis
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- Fidec Corporation
- Registration Number
- NCT05166031
Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants
Phase 3
Completed
- Conditions
- Poliomyelitis
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Fidec Corporation
- Target Recruit Count
- 905
- Registration Number
- NCT05033561
- Locations
- 🇩🇴
Clinica Cruz Jiminián, Santo Domingo, Dominican Republic
🇩🇴Hospital Universitario Maternidad Nuestra Señora de la Altagracia, Santo Domingo, Dominican Republic
A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine
Phase 2
Completed
- Conditions
- Poliomyelitis
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- Fidec Corporation
- Target Recruit Count
- 1025
- Registration Number
- NCT03554798
- Locations
- 🇵🇦
Cevaxin Vaccination Center, Panamá, Panama
- Prev
- 1
- 2
- 3
- Next
News
No news found